SLN - Silence Therapeutics PLC - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SLN is currently covered by 4 analysts with an average price target of $50.44. This is a potential upside of $32.61 (182.89%) from yesterday's end of day stock price of $17.83.

Silence Therapeutics PLC's activity chart (see below) currently has 2 price targets and 32 ratings on display. The stock rating distribution of SLN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.31% with an average time for these price targets to be met of 131.75 days.

Highest price target for SLN is $75, Lowest price target is $15, average price target is $50.44.

Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 08-Oct-2024. First documented stock forecast 18-Nov-2020.

Best performing analysts who are covering SLN - Silence Therapeutics PLC:

Keay Nakae Michael Ulz Patrick Trucchio Thomas Shrader

Currently out of the existing stock ratings of SLN, 30 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$49

$31.32 (177.15%)

$49

28 days ago
(08-Oct-2024)

6/9 (66.67%)

$29.65 (153.23%)

223

Buy

$75

$57.32 (324.21%)

$75

2 months 6 days ago
(30-Aug-2024)

0/10 (0%)

$55.91 (292.88%)

Buy

$55

$37.32 (211.09%)

$55

2 months 20 days ago
(16-Aug-2024)

2/7 (28.57%)

$39.31 (250.54%)

277

Buy

$15

$-2.68 (-15.16%)

$32

11 months 21 days ago
(15-Nov-2023)

1/2 (50%)

$5.58 (59.24%)

27

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SLN (Silence Therapeutics PLC) average time for price targets to be met?

On average it took 131.75 days on average for the stock forecasts to be realized with a an average price target met ratio 36.31

Which analyst has the current highest performing score on SLN (Silence Therapeutics PLC) with a proven track record?

KEAY NAKAE

Which analyst has the current lower performing score on SLN (Silence Therapeutics PLC) with a proven track record?

THOMAS SHRADER

Which analyst has the most public recommendations on SLN (Silence Therapeutics PLC)?

Keay Nakae works at CHARDAN CAPITAL and has 2 price targets and 6 ratings on SLN

Which analyst is the currently most bullish on SLN (Silence Therapeutics PLC)?

Patrick Trucchio with highest potential upside - $57.32

Which analyst is the currently most reserved on SLN (Silence Therapeutics PLC)?

Thomas Shrader with lowest potential downside - -$2.68

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?